| References: |
8-Bromo-cAMP improves the reprogramming efficiency of human neonatal foreskin fibroblast (HFF1) cells. In bronchial epithelial cells, 8-Bromo-cAMP decreases HDE-stimulated tumor necrosis factor (TNF)-α-converting enzyme (TACE; ADAM-17) activity and subsequent TNF-α release. For the detailed information of 8-Bromo-cAMP, the solubility of 8-Bromo-cAMP in water, the solubility of 8-Bromo-cAMP in DMSO, the solubility of 8-Bromo-cAMP in PBS buffer, the animal experiment (test) of 8-Bromo-cAMP, the cell expriment (test) of 8-Bromo-cAMP, the in vivo, in vitro and clinical trial test of 8-Bromo-cAMP, the EC50, IC50,and affinity,of 8-Bromo-cAMP, For the detailed information of 8-Bromo-cAMP, the solubility of 8-Bromo-cAMP in water, the solubility of 8-Bromo-cAMP in DMSO, the solubility of 8-Bromo-cAMP in PBS buffer, the animal experiment (test) of 8-Bromo-cAMP, the cell expriment (test) of 8-Bromo-cAMP, the in vivo, in vitro and clinical trial test of 8-Bromo-cAMP, the EC50, IC50,and affinity,of 8-Bromo-cAMP, Please contact DC Chemicals. |
